On this page

Ibuprofen 200mg

Over-the-counter ANDA Official labelling
Informational index, not medical advice. Content is reproduced from public FDA and NLM data. Always confirm against the manufacturer's current prescribing information. Report adverse events to FDA MedWatch.

Overview

Brand name
Ibuprofen 200mg
Generic name
Ibuprofen 200mg
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA
Labeler
Allegiant Health
Product type
Human Otc Drug
DEA schedule
Not scheduled
Active ingredients
1
NDC product codes
3
Packages
12
Data completeness
76% of corroborating sources present

Active ingredients

Source: NDC Directory
Active ingredients and strengths as listed in the NDC Directory.
Ingredient Strength RxCUI Monograph
Ibuprofen 200 mg/1 310965 View

Forms, strengths and routes

Source: NDC Directory
Dosage form
Tablet
Route of administration
Oral
Presentations
15

Pharmacologic classes are listed in the class section below.

Pharmacologic class

Source: NDC Directory
Established pharmacologic classes (EPC), mechanisms of action (MoA), chemical structures (CS) and physiologic effects (PE).
Class Type Browse
Anti-Inflammatory Agents EPC All 251 members
Cyclooxygenase Inhibitors [MoA] MoA All 251 members
Non-Steroidal [CS] CS All 251 members
Nonsteroidal Anti-inflammatory Drug [EPC] EPC All 251 members

Regulatory status

Source: Drugs@FDANDC Directory
Application number
079174
Application type
ANDA · Abbreviated New Drug Application
Approval date
December 10, 2010
Sponsor
GRANULES INDIA
Products on application
1
Submissions recorded
5
Products approved under application 079174.
Product Trade name Form Strength Ingredient Status TE Flags
079174-001 IBUPROFEN TABLET IBUPROFEN Over-the-counter —

Approval history

Source: Drugs@FDA
Most recent submissions on application 079174.
Type No. Action Status Date Review
Supplement 14 Labeling Approved April 11, 2018 Standard
Supplement 10 Manufacturing (CMC) Approved April 11, 2018 —
Supplement 17 Labeling Approved March 23, 2018 Standard
Supplement 1 Labeling Approved April 13, 2015 Standard
Original application 1 Approved December 10, 2010 —

Prescribing information

Source: openFDA Drug Labeling

Reproduced verbatim from the Structured Product Labeling submitted to the FDA (effective 20211116). This is the manufacturer's labelling text, not a summary and not advice.

HUMAN OTC DRUG · 20211116 HUMAN OTC DRUG · 20191212

Indications and Usage

openFDA Drug Labeling

Use(s) temporarily relieves minor aches and pains due to: headache toothache backache menstrual cramps the common cold muscular aches minor pain of arthritis temporarily reduces fever

Purpose Pain reliever/fever reducer

Dosage and Administration

openFDA Drug Labeling

Directions do not take more than directed the smallest effective dose should be used adults and children 12 years and over: take 1 caplet every 4 to 6 hours while symptoms persist if pain or fever does not respond to 1 caplet, 2 caplets may be used do not exceed 6 caplets in 24 hours, unless directed by a doctor children under 12 years: ask a doctor

Warnings Allergy alert: Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include: hives facial swelling asthma (wheezing) shock skin reddening rash blisters If an allergic reaction occurs, stop use and seek medical help right away. Stomach bleeding warning: This product contains a nonsteroidal anti-inflammatory drug (NSAID), which may cause severe stomach bleeding. The chances are higher if you: are age 60 or older have had stomach ulcers or bleeding problems take a blood thinning (anticoagulant) or steroid drug take other drugs containing prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen, or others) have 3 or more alcoholic drinks every day while using this product take more or for a longer time than directed. Heart attack and stroke warning: NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed. Do not use if you have ever had an allergic reaction to any other pain reliever/fever reducer right before or after heart surgery Ask a doctor before use if stomach bleeding warning applies to you you have problems or serious side effects from taking pain relievers or fever reducers you have a history of stomach problems, such as heartburn you have high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or had a stroke you are taking a diuretic Ask a doctor or pharmacist before use if you are under a doctor’s care for any serious condition taking aspirin for heart attack or stroke, because ibuprofen may decrease this benefit of aspirin taking any other drug When using this product take with food or milk if stomach upset occurs Stop use and ask a doctor if you experience any of the following signs of stomach bleeding: feel faint vomit blood have bloody or black stools have stomach pain that does not get better you have symptoms of heart problems or stroke: chesst pain trouble breathing weakness in one part or side of body slurred speech leg swelling pain gets worse or lasts more than 10 days fever gets worse or lasts more than 3 days redness or swelling is present in the painful area any new symptoms appear Pregnancy/Breastfeeding If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use ibuprofen at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery Keep out of reach of children In case of overdose, get medical help or contact a Poison Control Center right (1-800-222-1222) away.

Do not use if you have ever had an allergic reaction to any other pain reliever/ fever reducer right before or after heart surgery

Ask a Doctor

openFDA Drug Labeling

Ask a doctor before use if stomach bleeding warning applies to you you have problems or serious side effects from taking pain relievers or fever reducers you have a history of stomach problems, such as heartburn you have high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or had a stroke you are taking a diuretic

Stop use and ask a doctor if you experience any of the following signs of stomach bleeding: feel faint vomit blood have bloody or black stools have stomach pain that does not get better you have symptoms of heart problems or stroke: chesst pain trouble breathing weakness in one part or side of body slurred speech leg swelling pain gets worse or lasts more than 10 days fever gets worse or lasts more than 3 days redness or swelling is present in the painful area any new symptoms appear

Active Ingredient

openFDA Drug Labeling

Active ingredient (in each caplet) Ibuprofen USP, 200mg (NSAID)* *nonsteroidal anti-inflammatory drug

Adverse event reports

Source: openFDA FAERS
283,546
FAERS reports mentioning this drug
as of 2026-09-25T03:42:24+00:00
A report count is not a risk measure. FAERS accepts voluntary and mandatory reports without establishing causation, and reporting is influenced by how widely a drug is used, how long it has been marketed, and media attention. FDA states that reports “do not prove that the drug caused the event”. Compare rates, not totals.

Attributed to this product's most-reported active ingredient: IBUPROFEN. Combination products with more than six active ingredients are not attributed, because a report count summed across a long ingredient list measures the list, not the medicine.

Packaging and NDCs

Source: NDC Directory
Every National Drug Code package associated with this medication. The NDC is the identifier used for dispensing, billing and pharmacovigilance in the United States.
Package NDC Product NDC Labeler Description Marketing start
69168-381-01 69168-381 Allegiant Health 1 BOTTLE in 1 CARTON (69168-381-01) / 100 TABLET in 1 BOTTLE November 16, 2021
69168-381-03 69168-381 Allegiant Health 250 TABLET in 1 BOTTLE (69168-381-03) November 16, 2021
69168-381-05 69168-381 Allegiant Health 500 TABLET in 1 BOTTLE (69168-381-05) November 16, 2021
69168-381-30 69168-381 Allegiant Health 1 BOTTLE in 1 CARTON (69168-381-30) / 30 TABLET in 1 BOTTLE November 16, 2021
69168-381-32 69168-381 Allegiant Health 100 TABLET in 1 BOTTLE (69168-381-32) May 18, 2022
69168-381-40 69168-381 Allegiant Health 1 BOTTLE in 1 CARTON (69168-381-40) / 40 TABLET in 1 BOTTLE November 16, 2021
69168-382-30 69168-382 Allegiant Health 1 BOTTLE in 1 CARTON (69168-382-30) / 30 TABLET in 1 BOTTLE December 23, 2014
69168-467-01 69168-467 Allegiant Health 1 BOTTLE in 1 CARTON (69168-467-01) / 100 TABLET in 1 BOTTLE August 12, 2025
69168-467-03 69168-467 Allegiant Health 250 TABLET in 1 BOTTLE (69168-467-03) October 17, 2024
69168-467-05 69168-467 Allegiant Health 500 TABLET in 1 BOTTLE (69168-467-05) October 17, 2024
69168-467-30 69168-467 Allegiant Health 1 BOTTLE in 1 CARTON (69168-467-30) / 30 TABLET in 1 BOTTLE August 12, 2025
69168-467-32 69168-467 Allegiant Health 100 TABLET in 1 BOTTLE (69168-467-32) October 17, 2024
69168-381 69168-381 Allegiant Health — November 16, 2021
69168-382 69168-382 Allegiant Health — December 23, 2014
69168-467 69168-467 Allegiant Health — October 10, 2024

Sources for this page

Every dataset that contributed a fact to this page.
Dataset Agency Used for
NDC Directory FDA Identity, ingredients, strengths, forms, routes, labelers, packages
Drugs@FDA FDA Application, sponsor, submissions, review documents, marketing status
Drug Labeling FDA / NLM Prescribing information reproduced above
FAERS FDA Adverse event report counts

Generated September 25, 2026 · 10 sections on this page.